SKIN:NASDAQSkinHealth Systems Inc. Analysis
Data as of 2026-08-31 - not real-time
$0.69
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $0.6914, SkinHealth Systems Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 12.3%. RSI sits at 51.0, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at $0.5670 up to resistance at $0.7800.
On valuation the read is undervalued — an earnings multiple of 3.6, absent a reliable peer benchmark. Consensus targets land 43.4% above where the shares trade now. Revenue is contracting at 7.8% on a -9.8% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 85.5%, a beta of 1.28 and a maximum drawdown of 77.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
On valuation the read is undervalued — an earnings multiple of 3.6, absent a reliable peer benchmark. Consensus targets land 43.4% above where the shares trade now. Revenue is contracting at 7.8% on a -9.8% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 85.5%, a beta of 1.28 and a maximum drawdown of 77.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
SkinHealth Systems Inc. SKIN reported $72.1 million in revenue for the quarter ended June 2026, representing a...Skinhealth Systems Reports Second Quarter 2026 Financial Results.LONG BEACH, Calif., Aug. 06, 2026 GLOBE NEWSWIRE -- SkinHealth Systems Inc. NASDAQ: SKIN "SkinHealth Systems" or the...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.01
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.01
- Analyst targets imply +43.4% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -9.8%
- Analyst targets imply +43.4% versus the current price
- Negative return on equity of -43.9%
Key Metrics & Analysis
Financial Health
Revenue Growth-7.80%
Profit Margin-9.80%
P/E Ratio3.6
ROE-43.89%
ROA-0.54%
Debt/Equity660.53
P/B Ratio1.6
Op. Cash Flow$22.0M
Free Cash Flow$27.5M
Technical Analysis
TrendBearish
RSI51.0
Support$0.57
Resistance$0.78
MA 20$0.67
MA 50$0.73
MA 200$1.01
MACDBullish
VolumeStable
Fear & Greed Index94.46
Valuation
Fair Value$1.46
Target Price$0.99
Upside/Downside43.43%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.28
Volatility85.48%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.